in a news release, the drug's manufacturer, amgen, said the list price will be 5 a month or ,900 annually. costs to patients may vary depending on insurance..
phil lempert: it's affordability. it's convenience. it's not having a lot of waste. people are more concerned about waste than ever before...
marketwatch: "new migraine drugs have promise -- and a ,500 price tag.".
refrain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks, name calling or inciting hatred against any community.